Differentiation of the regioisomeric 2-, 3-, and 4-trifluoromethylphenylpiperazines (TFMPP) by GC-IRD and GC-MS

Forensic Science International

Volumn 188, Issue 1-3, 2009, Pages 31-39

  Maher, Hadir M ^a   Awad, Tamer ^b   Clark, C Randall ^b  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b AUBURN UNIVERSITY   (United States)

Author keywords

GC IRD; GC MS; Regioisomers; TFMPP; Trifluoromethylphenylpiperazine

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 2 TRIFLUOROMETHYLPHENYLPIPERAZINE; 3 TRIFLUOROMETHYLPHENYLPIPERAZINE; 4 TRIFLUOROMETHYLPHENYLPIPERAZINE; NITROGEN; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; INFRARED SPECTROSCOPY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; STEREOCHEMISTRY; STRUCTURE ANALYSIS;

EID: 67349169498     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2009.03.009     Document Type: Article

References (20)

1. 2 binding characteristics of some quipazine analogues. J. Med. Chem. 29 (1986) 2375-2380
2. Glennon R.A. Central serotonin receptors as targets for drug research. J. Med. Chem. 30 (1987) 1-12
3. de Boer D., Bosman I.J., Hidvégi E., Manzoni C., Benkö A.A., dos Reys L.J.A.L., and Maes R.A.A. Piperazine-like compounds: a new group of designer drug-of-abuse on the European Market. Forensic Sci. Int. 121 (2001) 47-56
4. Staack R.F., Paul L.D., Schmid D., Roider G., and Rolf B. Proof of a 1-(3-chlorophenyl)piperazine (mCPP) intake-use as adulterant of cocaine resulting in drug-drug interactions?. J. Chromatogr. B 855 (2007) 127-133
5. Tsutsumi H., Katagi M., Miki A., Shima N., Kamata T., Nishikawa M., Nakajima K., and Tsuchihashi H. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine. J. Chromatogr. B 819 (2005) 315-322
6. Haroz R., and Greenberg M.I. New drugs of abuse in North America. Clin. Lab. Med. 26 (2006) 147-164
7. Yarosh H.L., Katz E.B., Coop A., and Fantegrossi W.E. MDMA-like behavioral effects of N-substituted piperazines in the mouse. Pharmacol. Biochem. Behav. 88 (2007) 18-27
8. Aalberg L., DeRuiter J., Sippola E., and Clark C.R. Gas chromatographic optimization studies on the side chain and ring regioisomers of methylenedioxymeth-amphetamine. J. Chromatogr. Sci. 42 (2004) 293-298
9. Awad T., DeRuiter J., and Clark C.R. GC-MS analysis of acylated derivatives of the side chain and ring regioisomers of methylenedioxymethamphetamine. J. Chromatogr. Sci. 43 (2005) 296-303
10. Awad T., Clark C.R., and DeRuiter J. Chromatographic and mass spectral studies on methoxymethcathinones related to 3,4-methylenedioxymethamphetamine. J. Chromatogr. Sci. 44 (2006) 155-161
11. Awad T., Clark C.R., and DeRuiter J. Chromatographic and mass spectral studies on methoxy methyl methamphetamines related to 3,4-methylenedioxymeth-amphetamine. J. Chromatogr. Sci. 45 (2007) 468-476
12. Awad T., Clark C.R., and DeRuiter J. GC-MS analysis of acylated derivatives of the side chain regioisomers of 4-methoxy-3-methyl phenethylamines related to methylenedioxymethamphetamine. J. Chromatogr. Sci. 45 (2007) 477-485
13. Awad T., DeRuiter J., and Clark C.R. GC-MS Analysis of the ring and side chain regioisomers of ethoxyphenethylamines. J. Chromatogr. Sci. 46 (2008) 671-679
14. Staack R.F., Fritschi G., and Maurer H.H. New designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP): gas chromatography/mass spectrometry and liquid chromatography/mass spectrometry studies on its phase I and II metabolism and on its toxicological detection in rat urine. J. Mass Spectrom. 38 (2003) 971-981
15. Peters F.T., Schaefer S., Staack R.F., Kraemer T., and Maurer H.H. Screening for and validated quantification of amphetamines as well as of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. J. Mass Spectrom. 38 (2003) 659-676
16. Vorce S.P., Shawn P., Holler J.M., Levine B., and Past M.R. Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS. J. Anal. Toxicol. 32 (2008) 444-450
17. Elliot S., and Smith C. Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP. J. Anal. Toxicol. 32 (2008) 172-177
18. Duncan W., and Soine W.H. Identification of amphetamine isomers by GC/IR/MS. J. Chromatogr. Sci. 26 (1988) 521-526
19. Kempfert K. Forensic drug analysis by GC/FT-IR. Appl. Spectrosc. 42 (1988) 845-849
20. Belal T., Awad T., DeRuiter J., and Clark C.R. GC-IRD methods for the identification of isomeric ethoxyphenethylamines and methoxymethcathinones. Forensic Sci. Int. 184 (2009) 54-63